These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7538095)

  • 41. Functional expression of human CD59 in transgenic mice.
    Somerville CA; Kyriazis AG; McKenzie A; Allison J; Pearse MJ; D'Apice AJ
    Transplantation; 1994 Dec; 58(12):1430-5. PubMed ID: 7528953
    [No Abstract]   [Full Text] [Related]  

  • 42. Progress in xenotransplantation.
    Cozzi E; Masroor S; Soin B; Vial C; White DJ
    Clin Nephrol; 2000 Apr; 53(4):suppl 13-8. PubMed ID: 10809429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human regulator of complement activation (RCA) gene family proteins and their relationship to microbial infection.
    Seya T
    Microbiol Immunol; 1995; 39(5):295-305. PubMed ID: 7565169
    [No Abstract]   [Full Text] [Related]  

  • 44. Signaling properties of CR3 (CD11b/CD18) and CR1 (CD35) in relation to phagocytosis of complement-opsonized particles.
    Fällman M; Andersson R; Andersson T
    J Immunol; 1993 Jul; 151(1):330-8. PubMed ID: 8326130
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of combined expression of human complement regulatory proteins and H-transferase on the inhibition of complement-mediated cytolysis in porcine embryonic fibroblasts.
    Lee JH; Lee HJ; Nahm KM; Jeon HY; Hwang WS; Paik NW; Rho HM
    Transplant Proc; 2006 Jun; 38(5):1618-21. PubMed ID: 16797369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement.
    Marschang P; Sodroski J; Würzner R; Dierich MP
    Eur J Immunol; 1995 Jan; 25(1):285-90. PubMed ID: 7531147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human complement regulatory proteins expressed in transgenic swine protect swine xenografts from humoral injury.
    McCurry KR; Diamond LE; Kooyman DL; Byrne GW; Martin MJ; Logan JS; Platt JL
    Transplant Proc; 1996 Apr; 28(2):758. PubMed ID: 8623384
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunization against tumor cell surface complement-regulatory proteins.
    Durrant LG; Spendlove I
    Curr Opin Investig Drugs; 2001 Jul; 2(7):959-66. PubMed ID: 11757799
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aspects of the Complement System in New Era of Xenotransplantation.
    Miyagawa S; Maeda A; Toyama C; Kogata S; Okamatsu C; Yamamoto R; Masahata K; Kamiyama M; Eguchi H; Watanabe M; Nagashima H; Ikawa M; Matsunami K; Okuyama H
    Front Immunol; 2022; 13():860165. PubMed ID: 35493484
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of transfected MACIF (CD59) on complement-mediated swine endothelial cell lysis, compared with those of membrane cofactor protein (CD46) and decay-accelerating factor (CD55).
    Miyagawa S; Shirakura R; Nakata S; Izutani H; Matsuda H; Iwata K; Nagasawa S; Terado A; Hatanaka M; Matsumoto M
    Transplant Proc; 1995 Feb; 27(1):328-9. PubMed ID: 7533401
    [No Abstract]   [Full Text] [Related]  

  • 51. The study of mitoxantrone as a potential immunosuppressor in transgenic pig renal xenotransplantation in baboons: comparison with cyclophosphamide.
    Ashton-Chess J; Meurette G; Karam G; Petzold T; Minault D; Naulet J; Tesson L; Plat M; Anegon I; Soulillou JP; Blancho G
    Xenotransplantation; 2004 Mar; 11(2):112-22. PubMed ID: 14962273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Attempts to prepare suitable complement regulatory molecules for clinical xenotransplantation.
    Miyagawa S; Matsunami K; Yoshitatsu M; Mikata S; Matsuda H; Shirakura R
    J Card Surg; 2001; 16(6):429-38. PubMed ID: 11925023
    [No Abstract]   [Full Text] [Related]  

  • 53. Transplantation of organs between species.
    White DJ
    Int Arch Allergy Immunol; 1992; 98(1):1-5. PubMed ID: 1378038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complement: a unique innate immune sensor for danger signals.
    Gasque P
    Mol Immunol; 2004 Nov; 41(11):1089-98. PubMed ID: 15476920
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complement and complement regulatory proteins as potential molecular targets for vascular diseases.
    Acosta J; Qin X; Halperin J
    Curr Pharm Des; 2004; 10(2):203-11. PubMed ID: 14754399
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ancient proteins and futuristic surgery: the role of complement in discordant xenograft rejection.
    Winkler M
    Transplant Proc; 2001; 33(7-8):3862-4. PubMed ID: 11750645
    [No Abstract]   [Full Text] [Related]  

  • 57. Complement receptors and phagocytosis.
    Brown EJ
    Curr Opin Immunol; 1991 Feb; 3(1):76-82. PubMed ID: 1675856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Control of complement activities for immunoisolation.
    Iwata H; Murakami Y; Ikada Y
    Ann N Y Acad Sci; 1999 Jun; 875():7-23. PubMed ID: 10415554
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conservation of plasma regulatory proteins of the complement system in evolution: humans and fish.
    Kemper C; Gigli I; Zipfel PF
    Exp Clin Immunogenet; 2000; 17(2):55-62. PubMed ID: 10810221
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities.
    Gasque P; Neal JW; Singhrao SK; McGreal EP; Dean YD; Van BJ; Morgan BP
    Mol Neurobiol; 2002 Feb; 25(1):1-17. PubMed ID: 11890454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.